Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 1861. Categories: , .

Product Description

Sales, Marketing, and R&D Trends Affecting the Healthcare Industry

Featured Briefs:

IMS Reports 16.9% Growth in 2001 U.S. Prescription Sales

2001 Sales and Market Share

Biological Response Modifiers Outpace Other Therapeutics in Cancer Adjuncts Market

New Technologies Boost Wound-Care Market
Sidebar: Adjunctive Therapies Continue to Grow

Survey Reveals Consumer Healthcare Attitudes, Health Information Sources, And Attitudes to Ads
Sidebar: Mars Study Reports Consumer Responses

Biotechnology Vital To Orphan Drug R&D, According To Tufts Analysis

Biotech ­Companies ­Embracing EDC?Technology

Follow up
CB Technologies Inc., Philadelphia, develops and delivers technology tools and services for life-sciences companies. For more information, visit
IMS Health, Fairfield, Conn., is a leading provider of information solutions to the pharmaceutical and healthcare industries. For more information, visit
Kalorama Information, New York, an imprint of, supplies the latest in independent market research for the life sciences. For more information, visit
MARS is a division of KMR, New York, an integrated global research, information, and software group with research ­operations in more than 30 countries, ­specializing in media and survey research solutions, and analysis software systems. (The Annual MARS Pharmaceutical Research Study is the first of several planned annual syndicated measurements of emerging market categories in the U.S.) For more information, visit
Tufts Center for the Study of Drug Development, Boston, is ­affiliated with Tufts University. It is the leading
independent source, both in the U.S. and abroad, for information about the efficiency and productivity of the research-based drug industry and the impact of government initiatives on the drug-development process. For more information, visit